Cell-Easy logo — Your Cell-Therapy Specialized CDMO

Cell-Easy

Your Cell-Therapy Specialized CDMO

Founded 2017 France France 35 employees Total: $7.80M Biotechnology, Health Care

General Information

Company Name Cell-Easy
Founded Year 2017
Location France France
Employees 35
Industries Biotechnology, Health Care
Social

BounceWatch is an independent company data service, not affiliated with Cell-Easy. To contact Cell-Easy, visit cell-easy.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About Cell-Easy

Cell-Easy is a France-based CDMO specialized in Cell Therapy. The company's mission is to accelerate Cell Therapy's path to market, with a focus on patient access. With expertise in cell culture across all cell types, Cell-Easy provides GMP development and manufacturing services for biotech, pharma, and public institutions. In addition to core CDMO services such as process diagnostics, development, GMP production, cell banking, cryostorage, and delivery, the company also supports sourcing of human biological materials and clinical trial setup. Since its establishment in 2017, Cell-Easy has been involved in 10 clinical trials, including projects with top 30 pharma companies, and has assisted clients in transitioning from autologous to allogeneic approaches. The latest funding round of €7.80M was led by Bpifrance on 28 February 2022. More information can be found at www.cell-easy.com.

Taxonomy: Cell Therapy, ATMP, CDMO, GMP Manufacturing, Clinical Trials Support, Cell Culture, Biological Materials Sourcing, Allogeneic Approaches, Preclinical Drug Development, Quality Control, NK Cell, Stem Cell, T Cell, Clinical Drug Development

Services & Products

Customized Process Development
GMP Manufacturing
Analytical Services

Target Customers

Biotech Companies Pharma Companies Academic Institutions

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Funding Round Cell €7.80M 1
Bpifrance
28 Feb 2022

Cell-Easy Alternatives & Competitors

View All Alternatives
Cell-Easy vs

Your CDMO Partner from Concept to Commercial for Cell & Gene Therapy Products

Series B
81 employees
Biotechnology, Health Care
Cell-Easy vs
PBS Biotech
PBS Biotech United States

Next Generation Single-Use Bioreactors

Venture round
100 employees
Biotechnology, Health Care
Cell-Easy vs

Developing Breakthrough Progenitor Cell and Protein Therapeutics

Series B
16 employees
Biotechnology, Health Care

FAQ About Cell-Easy

Your Cell-Therapy Specialized CDMO
Cell-Easy was founded in 2017.
Cell-Easy is headquartered in France.
Cell-Easy operates in Biotechnology and Health Care. Its work centres on Cell Therapy, ATMP, CDMO and GMP Manufacturing. Its customers include Biotech Companies, Pharma Companies and Academic Institutions.
Cell-Easy has approximately 35 employees.
Cell-Easy has completed 1 funding round, raising a total of $7.80M.
Cell-Easy offers: Customized Process Development, GMP Manufacturing, Analytical Services.
Top alternatives and competitors to Cell-Easy include Cognate BioServices, a Charles River Company, PBS Biotech, Stemedica Cell Technologies, Inc, Histocell. Regenerative Medicine, Sana Biotechnology, Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Cell-Easy and Cognate BioServices, a Charles River Company are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Cell-Easy, https://bouncewatch.com/company/cell-easy, updated 7 June 2025. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes